Last updated: 2026-09-08 20:48:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Idexx Laboratories Inc. (IDXX) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $520.40, with a market capitalization of $42.18B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $518.55 to $769.98. This page covers its latest market performance, valuation, price trends and company information.
$42.18B | |
$528.42 | |
$769.98 | |
$5.57 | |
$535.38 | |
382.84K | |
618.32K | |
-- | |
$769.98 | |
$518.55 | |
-- | |
-- |
Idexx Laboratories Inc. (IDXX) is trading at $525.50 in after-hours trading as of 2026-09-08 20:43:00, down 1.85% ($9.88) from the regular-session close of $535.38.
After-hours trading shows how investors are pricing IDXX after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Idexx Laboratories Inc. (IDXX) moved from $545.08 to $520.40, representing a decline of 4.53% ($24.69).
The stock traded between $519.62 and $561.24 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 498.87 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.7%
IDXX is currently trading at $520.40, placing it 0.7% of the way from its 52-week low of $518.55 to its 52-week high of $769.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 11000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Idexx Laboratories Inc. (IDXX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.